Ever Stricter Trial Transparency Rules Driving Demand for Disclosure Expertise
As clinical trial transparency requirements continue to expand globally, pharmaceutical companies face increasing complexity in meeting disclosure obligations across registries, regulatory authorities, and public information platforms.
Our Co-CEOs, Dr. Pooja Phogat and Dr. Stuart Donald share their insights on how increasingly stringent global clinical trial transparency requirements are driving demand for specialized disclosure expertise across the life sciences industry.
Read this article to learn more how the clinical trial transparency space is shaping up: Ever Stricter Trial Transparency Rules Driving Demand for Disclosure Expertise